FAIRFIELD, Conn.--(BUSINESS WIRE)--Calmare Therapeutics Reports Year End; Fourth Quarter 2014 Results Year-End: Revenues up 60%; Device Sales up 88%; G&A Down 22%; 4th Quarter: Revenues Down 52%; Device Sales Down 33%; G&A Down 14%